Observations made by Bailey et al. indicate that ICAM-1 promotes T cell activation and T cell/tumor cell interaction by highly specific binding of ICAM-1 expressed on tumor cells and the corresponding lymphocyte function-associated antigen-1 (LFA-1) expressed on lymphocytes [18,19]. The gene discussed is ICAM1; the disease is neoplasm.